| Patent Number |
Title Of Patent |
Date Issued |
| 7553854 |
6-O-substituted benzoxazole and benzothiazole compounds and methods of inhibiting CSF-1R signali |
June 30, 2009 |
| Benzoxazole and benzothiazole compounds and the stereoisomers, tautomers, solvates, oxides, esters, and prodrugs thereof and pharmaceutically acceptable salts thereof are disclosed. Compositions of the compounds, either alone or in combination with at least one additional therapeutic |
| 7420089 |
Hydroxamates as therapeutic agents |
September 2, 2008 |
| The present invention is directed to certain hydroxamate derivatives that are useful in the treatment of hepatitis C. These compounds are also inhibitors of histone deacetylase and are therefore useful in the treatment of diseases associated with histone deacetylase activity. Pharmac |
| 7368572 |
Acetylene derivatives as inhibitors of histone deacetylase |
May 6, 2008 |
| The present invention is directed to certain hydroxamate derivatives that are inhibitors of histone deacetylase and are therefore useful in the treatment of diseases associated with histone deacetylase activity. Pharmaceutical compositions and processes for preparing these compounds |
| 7276612 |
Hydroxamates as therapeutic agents |
October 2, 2007 |
| The present invention is directed to certain hydroxamate derivatives that are useful in the treatment of hepatitis C. These compounds are also inhibitors of histone deacetylase and are therefore useful in the treatment of diseases associated with histone deacetylase activity. Pharmac |
| 6861419 |
Substituted 1, 4-thiazepine and analogs as activators of caspases and inducers of apoptosis and |
March 1, 2005 |
| The present invention is directed to substituted 1,4-thiazepine and analogs thereof, represented by the general Formula I: ##STR1##wherein the dashed lines, A.sup.1, A.sup.2, A.sup.3, X.sup.1 and R.sup.1 are defined herein. The present invention also relates to the discovery that com |
